Given the anti-inflammatory and cytoprotective effects of recombinant APC administration in disease models29–32, including in ischemic stroke33,34, it is conceivable that AB002 may also impart beneficial effects on chronic inflammation or anemia in this patient population. The gene discussed is APC; the disease is anemia (phenotype).